1. Monash Health
  2. Monash Health research
  3. Articles
Please use this identifier to cite or link to this item: https://repository.monashhealth.org/monashhealthjspui/handle/1/41616
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSehgal A.en
dc.contributor.authorMalikiwi A.en
dc.contributor.authorSasi A.en
dc.contributor.authorTan K.en
dc.date.accessioned2021-05-14T14:15:45Zen
dc.date.available2021-05-14T14:15:45Zen
dc.date.copyright2014en
dc.date.created20150121en
dc.date.issued2015-01-21en
dc.identifier.citationEuropean Journal of Pediatrics. 173 (12) (pp 1651-1654), 2014. Date of Publication: December 2014.en
dc.identifier.issn0340-6199en
dc.identifier.urihttps://repository.monashhealth.org/monashhealthjspui/handle/1/41616en
dc.description.abstractVasopressin is emerging as a therapeutic adjunct option towards treatment of shock states in the pediatric population. Its effects on pulmonary vasculature are less well understood. This report describes a 5-month-old infant with nitric oxide-unresponsive pulmonary hypertension, oxygenation failure, and systemic hypotension. Vasopressin therapy improved oxygenation and blood pressure and biventricular function, allowing weaning of nitric oxide and inotropic support. No decrease in coronary flow was noted. Conclusion(s): Vasopressin could be considered as an adjunct option in infants with pulmonary hypertension and systemic hypotension. Echocardiographic monitoring during treatment is recommended.Copyright © 2013, Springer-Verlag Berlin Heidelberg.en
dc.languageEnglishen
dc.languageenen
dc.publisherSpringer Verlag (E-mail: service@springer.de)en
dc.relation.ispartofEuropean Journal of Pediatricsen
dc.titleVasopressin as an adjunct therapy for pulmonary hypertension: a case report.en
dc.typeArticleen
dc.identifier.doihttp://monash.idm.oclc.org/login?url=http://dx.doi.org/10.1007/s00431-013-2225-yen
dc.publisher.placeGermanyen
dc.identifier.pubmedid24297672 [http://www.ncbi.nlm.nih.gov/pubmed/?term=24297672]en
dc.identifier.source52896507en
dc.identifier.institution(Malikiwi, Sasi, Tan, Sehgal) Monash Newborn, Monash Children's Hospital, Melbourne, Australia (Tan, Sehgal) Department of Pediatrics, Monash University, 246, Clayton Road, Clayton, Melbourne, VIC 3168, Australiaen
dc.description.addressA. Sehgal, Department of Pediatrics, Monash University, 246, Clayton Road, Clayton, Melbourne, VIC 3168, Australiaen
dc.description.publicationstatusIn-Processen
dc.rights.statementCopyright 2019 Elsevier B.V., All rights reserved.en
dc.subect.keywordsPulmonary hypertension Vasopressinen
dc.identifier.authoremailSehgal A.; Arvind.sehgal@monash.eduen
item.fulltextNo Fulltext-
item.cerifentitytypePublications-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.grantfulltextnone-
item.openairetypeArticle-
crisitem.author.deptPaediatric - Neonatal (Monash Newborn)-
crisitem.author.deptPaediatric - Neonatal (Monash Newborn)-
crisitem.author.deptPaediatric - Neonatal (Monash Newborn)-
crisitem.author.deptHudson Institute - The Ritchie Centre-
Appears in Collections:Articles
Show simple item record

Page view(s)

24
checked on Feb 7, 2025

Google ScholarTM

Check


Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.